Recent studies have suggested that Sema3A could interrupt the itch-scratch cycle by inhibiting the extension and sprouting of C-fiber in the epidermis, thereby alleviating the skin lesions and scratching behavior of NC/Nga mice, a model of atopic dermatitis (AD), in a dose-dependent manner22,23. This evidence concerns the gene SEMA3A and Alzheimer disease.